NCT05109637View on ClinicalTrials.gov

A Study to Assess the Clinical Validity of Konectom™ in Adults Living With Neuromuscular Disorders

NACompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

July 10, 2023

Study Completion Date

July 25, 2023

Conditions
Spinal Muscular Atrophy
Interventions
DEVICE

Konectom NMD Application

Administered as specified in the treatment arm.

Trial Locations (5)

30625

Research Site, Hanover

45147

Research Site, Essen

69120

Research Site, Heidelberg

80336

LMU Klinikum Friedrich-Baur-Institute, Dept. of Neurology, Munich

01307

Research Site, Dresden

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY